Evidence map›Paper›PMID 39925376›Full record

ArticleFrontiers in cellular and infection microbiology2025

Evaluation of the transmission-blocking potential of

Di Zhang, Yan Zhao, Dongyan Liu, Fei Liu, Pengbo Liu, Biying Zhang, Zifang Wu, Wanlapa Roobsoong, Sirasate Bantuchai, Sataporn Thongpoon and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Di Zhang *Department of Immunology, College of Basic Medical Sciences, China Medical University, Shenyang, China.
Yan Zhao *Department of Immunology, College of Basic Medical Sciences, China Medical University, Shenyang, China.
Dongyan Liu *ShengJing Hospital of China Medical University, Department of Gastroenterology and Medical Research Center, Shenyang, Liaoning, China.
Fei LiuDepartment of Immunology, College of Basic Medical Sciences, China Medical University, Shenyang, China.
Pengbo LiuDepartment of Immunology, College of Basic Medical Sciences, China Medical University, Shenyang, China.
Biying ZhangDepartment of Immunology, College of Basic Medical Sciences, China Medical University, Shenyang, China.
Zifang WuDepartment of Immunology, College of Basic Medical Sciences, China Medical University, Shenyang, China.
Wanlapa RoobsoongMahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Sirasate BantuchaiMahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Sataporn ThongpoonMahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Piyarat SripooroteMahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Meilian WangDepartment of Pathogen Biology, College of Basic Medical Sciences, China Medical University, Shenyang, China.
Liwang CuiDepartment of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, United States.
Yaming CaoDepartment of Immunology, College of Basic Medical Sciences, China Medical University, Shenyang, China.

Funding

Southeast Asia Malaria Research CenterU19AI089672 · NIAID · UNIVERSITY OF SOUTH FLORIDA · PI CUI, LIWANG · 2010 to 2023
$28.9M
Antigen discovery for transmission-blocking vaccines in Plasmodium vivaxR01AI150533 · NIAID · CHINA MEDICAL UNIVERSITY · PI CAO, YAMING · 2020 to 2024
$677k
NIAID NIH HHS R01 AI150533NIAID NIH HHS U19 AI089672
6 · The paper itself

Abstract

Background: Methods and findings: In this study, we constructed a transgenic strain, Conclusion: Pvg37 is a promising candidate for

Indexed as

Antigens, ProtozoanMalaria VaccinesMalaria, VivaxPlasmodium vivaxProtozoan ProteinsAnimalsAnophelesAntibodies, ProtozoanFemaleHumansMaleMicePlasmodium bergheiRabbitsAntibodies, ProtozoanAntigens, ProtozoanMalaria VaccinesProtozoan ProteinsgametocytePlasmodium vivaxpolypeptidetransgenic parasitetransmission-blocking vaccine

Identifiers

PMID39925376
PMCPMC11802531

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.